Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6373.0000 -89.50 (-1.38%)
NSE Nov 21, 2025 15:31 PM
Volume: 130.8K
 

6373.00
-1.38%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 12% YoY to | 890 crore (I-direct estimate: | 959 crore), mainly due to loss of sales and delays of export shipments of...
Deven Choksey increased Accumulate price target of Divi's Laboratories Ltd. to 6795.0 on 20 Nov, 2025.
More from Divi's Laboratories Ltd.
Recommended